Key Financial Figures - Q1 FY27 Performance
Consolidated Financials:
- Revenue: ₹53,972 million (38% YoY growth)
- EBITDA: ₹9,198 million (92% YoY growth)
- EBITDA Margin: 17% (480 basis points YoY expansion)
- Normalized EBITDA (after ₹825 million forex derivative adjustment): ₹8,373 million (78% YoY growth)
- Normalized EBITDA Margin: 15.5%
- Net Profit After Tax (PAT): ₹4,233 million (Net margin of 7.8%)
- Incremental Revenue: ₹14,753 million
- Incremental EBITDA: ₹4,410 million
Volume Metrics:
- Total Sales Volume: 173,471 metric tons (1.7% YoY growth)
- Packaging Films Volume: 136,186 metric tons (4.9% YoY growth)
- Packaging Volume: 37,285 metric tons (8.4% YoY decline)
Geographic Performance Breakdown
India Operations:
- Packaging Films sales volume increased 9.1% QoQ to 29,323 metric tons
- Domestic demand improved sequentially as converters resumed purchases after price normalization in May-June
Americas Operations:
- Sales volume increased 18% YoY to 31,724 metric tons
- Growth supported by US government push for domestic production and onshoring
Europe Operations:
- Sales volume flat YoY at 35,653 metric tons
- Continued pressure from low-priced imports with demand expected to moderate next quarter due to seasonal holidays
Middle East and Africa Operations:
- Volumes increased 16.5% sequentially and 14.9% YoY to 39,486 metric tons
- Driven by strong local and regional sourcing as customers derisk supply chains amid West Asia crisis
- Egypt led growth, while Nigeria benefited from robust export opportunities and improving domestic demand
Capital Expenditure Update
Q1 FY27 Capex: ₹4,782 million allocated across key projects:
- Egypt Aseptic facility: ₹1,236 million
- Mexico WPP bags: ₹205 million
- Noida Sector 155 recycling unit: ₹320 million
- Dharwad BOPP Line: ₹215 million
Project Commissioning Status:
- 39,000 MTPA recycling plant at Noida Sector 155 commissioned on April 30, 2026
- 80-million-unit WPP bags plant in Mexico commissioned on July 31, 2026
- Greenfield Aseptic project in Egypt (12 billion packs capacity) remains on schedule for FY27 commissioning
Price Realization Trends
Management indicated significant price increases compared to pre-war levels:
- BOPP prices: 25-32% higher from February 2026 levels
- BOPET prices: 30-35% higher from February 2026 levels
FY27 Guidance and Outlook
Management provided the following guidance for FY27:
- 35% growth in top line compared to FY26
- 35% growth in bottom line compared to FY26
- Debt-EBITDA ratio improved from 4.5x in FY26 to 3.5x in Q1 FY27, expected to reach 3x by FY28
- Volume expected to double by FY29 from current levels
Growth Drivers and Strategy
- 91% of incremental EBITDA contributed by overseas operations
- Margin expansion driven by operational leverage, stronger realizations, pass-through of higher raw material costs, currency tailwinds, and localized sourcing premiums
- Strategic shift toward high-margin products in flexible packaging business
- Derisked global business model with manufacturing proximity to customers across geographies
- Focus on value-added products expected to constitute 60-70% of future capex allocation
Challenges Mentioned
- Packaging volumes declined 8.4% YoY due to strategic shift toward high-margin products in India and softness in Aseptic Packaging from duty-free imports at aggressive prices
- Overseas volumes impacted by larger pack sizes mix and disruptions in consignment deliveries due to West Asia crisis
- Europe facing continued pressure from low-priced imports
Tax Optimization
Management highlighted that tax expense is optimizing due to significant margins generated from geographies with favorable tax brackets (Egypt, European and US territories, Mexico).
Interest Cost Reduction
Company currently rated AA- by CRISIL and India Ratings. Management targets reducing interest costs by 1% within the next year, having already achieved 0.3-0.4% reduction in Q1.
Capacity Utilization Targets
- Egypt Aseptic plant: Targeting 30% capacity utilization in first year, 60-70% in second year, and 100% by third year
- Current domestic utilization at 70-73% with significant headroom in specialty segments (Metalizer, ultra-high barrier Films at 30-40% utilization)
Raw Material Trends
Raw material prices moving up but not to the extent of finished goods prices. Management expressed confidence in maintaining current margins regardless of price normalization.
#Tags: #UFlex #Q1Earnings #SEBIDisclosure #Packaging #GrowthOutlook #Positive